InMode (INMD) said on Thursday that it expects to release its financial results for the second quarter 2025 before the Nasdaq market opens on Wednesday, July 30 ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Nebius operates as an AI-focused cloud provider with usage-based revenue and growing subscription/contract revenues. Check out why I rate NBIS stock a buy.

DBMF gives retail investors access to CTA-style strategies with hedging potential, despite lagging traditional portfolios.

Lazydays (GORV) announces a 1-for-30 reverse stock split effective July 11, 2025, aiming to regain Nasdaq compliance.

BTCS is a U.S.-based digital asset company that has recently gained significant attention after years of low market cap.

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

UnitedHealth Group Incorporated faces challenges amidst DOJ investigations and margin pressures. Click for my UNH earnings ...

Realty Income remains a top REIT pick for high, resilient income. Click to learn about a game-changing catalyst for O and its ...

Deutsche Bank began coverage of Micron Technology ( NASDAQ: MU) with a Buy rating and a $150 price target. Shares of Micron ...

Elon Musk's shifting focus and political ambitions have raised concerns about his commitment as CEO to Tesla, Inc. Learn more about TSLA stock here.

Blue Bird's valuation shows promise yet faces growth challenges in a maturing market. Click here to read an analysis of BLBD ...